An end-to-end industrialization roadmap for autologous cell therapies: specificities and challenges, leveraging automation for scalability with the Cocoon® Platform, and building a vein-to-vein network to achieve ‘just-in-time’ delivery of therapies.
You may also be interested in:
Latest content
Latest briefing from the Knowledge Center